George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Apollon is a medical cannabis company based in Jamaica, where it holds a suite of licences and is fully regulated, allowing the company to work with full spectrum oils inclusive of THC. The company plans, using its own formulations, to develop medicines for conditions that afflict humans in the modern world.
Apollon
www.apollon.org.uk/
I stand corrected. You are quite right LuckyBob that is a much better way to put it.
Apollon is full spectrum..
Apollon Formularies
@apollon_uk
·
1h
Interested in #MedicalCannabis stocks? Apollon #APOL will be joining
@AquisStockEx
soon and will be one of the very few listed European companies able to undertake medically supervised treatments using newly developed formulations inclusive of #THC...
https://total-market-solutions.com/2021/03/investing-in-the-uks-small-cap-medicinal-cannabis-stocks/
Anyone talking solely about thc is selling the prospects short.
Full spectrum oil , the entourage effect , this is where medical science is going . Its a little understood subject and any company doing research on the benefits of this rather than isolating single component is going to discover a whole array of possible treatments.
As I said last week , which seemed to go over peoples heads, perhaps my own fault, the world leader in this sector has for decades been Israel, which surprised me.
The US has done very little research for medical use due to two main factors, federal law and big pharma who are not interested in going this direction for fear of losing money from other ineffective treatment. Cancer treatment is a business.
Anyone interested should watch running from the cure.
Though I take bold claims with a pinch of salt , the potential spectrum of serious illnesses that can be treated, life changing results from cannabis oil, is immense.
Also worth looking up the documentary "the scientist"
Its over an hour long but its worth a watch , its about the guy who discovered the endocannibinoid system that exists in our body naturally.
It may not be directly related to this company but it will give some a basic understanding of the potential of medical use of cannabis oil and since that's one of the avenues that's going to be explored by apollon its relevant.
I personally know people who self treat for illnesses like arthritis, MS, chronic back pain, nerve damage, migraine, epilepsy ect. It can give people who have spent a life in pain and not functioning , unable to work, their lives back.
Any country that supports the research is paving the way for future generations.
Apollon Formularies
Another intriguing name to look out for is Apollon Formularies, a medical cannabis company based in Jamaica preparing for listing on the Aquis Exchange.
Interviewed by Sarah Lowther for TMS earlier this month, Apollon’s Head of Business Development Stene Jacobs said that although the book is already closed after a substantially oversubscribed fundraise, for those who missed out ‘there is a second round of fundraising that will happen within 2021’.
Apollon uses machine learning AI technology to offer personalised clinical treatment, analysing data to identify the best combinations of cannabinoids to target and optimise prescriptions for each customer, producing tailored solutions for nausea, pain, sleep, anti-inflammatory, seizures, and appetite disorders. The company holds a suite of licences and is fully regulated, allowing the company to work with products that include elements of THC in addition to CBD: there is evidence that THC also has highly effective medicinal properties. The company’s technologies are overseen by CEO Dr Stephen Barnhill, an early pioneer in the use of AI techniques in medicine, primarily in the field of cancer diagnostics.
Apollon runs an in-patient medical cannabis treatment facility in Jamaica, where more than 400 patients have been treated in the past year, and which the company plans to expand to 130-person capacity. Another Apollon innovation is a patent pending 3D pharmaceutical printer, designed to overcome import and export regulations on cannabinoids and THC. Purchasing companies – if fully licensed – can order specific formulation ‘recipes’ to be emailed over to a printer, allowing Apollon formulations to be printed ‘in house’ using bio ink.
Apollon Formularies Retweeted
Total Market Solutions
@TMSreach
Time to invest in the UK’s Small Cap Medicinal #Cannabis Stocks?
“...Backed by a growing consumer base, increasing recognition from financial regulators and governments the sector is on a strong upwards trajectory…”
#APOL #CBX #FFWD #KNB #LIFE
MrTHC, thanks for the link. A decent overview of where the fledgling Cannabis market is at the moment and decent PR for Apollon.
Interesting to read about the listed stocks being shorted, which will not be allowed on Aquis Exchange. The fact that the placing was also heavily oversubscribed should also give Apollon a lift when the RTO becomes effective.
Apollon Formularies Retweeted
Total Market Solutions
@TMSreach
·
3h
Time to invest in the UK’s Small Cap Medicinal #Cannabis Stocks?
“...Backed by a growing consumer base, increasing recognition from financial regulators and governments the sector is on a strong upwards trajectory…”
#APOL #CBX #FFWD #KNB #LIFE
https://twitter.com/apollon_uk
https://total-market-solutions.com/2021/03/investing-in-the-uks-small-cap-medicinal-cannabis-stocks/
Ok I see what you were talking about. The difference is that they are cultivation only Kenny100. Cultivation is a small profit business as it is easily commoditised as it isn't hard to grow. I was meaning we are the only company allowed to undertake research on THC with patients and to make drugs.
I have no real interest in those that just grow, look to Canada as the example of what too many cultivators do to the market…
This is pharma country..
The real barrier to entry is the R&D side of our business and that is hard to replicate .
MR THC about 4 years ago, I phoned the AfriAG office a waste of time IMHO
Thanks for the assist re Sting..........
The info you asked about bud...........
https://cannabishealthnews.co.uk/2021/01/11/uk-grants-second-licence-to-grow-high-thc-medical-cannabis/#:~:text=Northern%20Leaf%20Ltd%20has%20secured%20the%20first%20full,medical%20cannabis%20for%20the%20UK%20and%20European%20market.
He worked for Apollon. I tried several times to get anyone from Afriag on the phone but it always rang out
Kenny100
Who are the other two that are licensed o do THC?
Link............. :+)
https://www.youtube.com/channel/UCWrBhuRUb7xUNQp7-cKioNQ/videos
Fancy being the communications officer, if so can you ask for all the video's to be on the web site please............. :+)
I know you could not do the job in the past, however with covid limiting you're travel maybe a temp position for you buddy.
Afriag Global Plc Share Chat - lse.co.uk
https://www.lse.co.uk/ShareChat.asp?ShareTicker=AFRI.PL&thread=7278A...
3 hours ago · Afriag Global Plc Share Chat. Chat About AFRI.PL Shares - Stock Quote, Charts, Trade History, Share Chat, Financial Terms Glossary.
Docs news flow to date has been very good... IMHO
Is the chap with the same surname as Doc, Doc's son?
A chap with the same surname made a Youtube video..................
Where is Sting living now m8 and what is his job and with who...........
In the early days at AfriAG we used to get posters that posted info and as time went by the posters no longer on BB at LSE
Will be number 3 with THC in UK m8...............
This is good research Kenny
thanks, this is going to grow there is no doubt, they are the only one that can do THC. Says it all really.
I have a reasonable holing and will buy more once this transaction gets completed. I contacted Apollon via their website and had a very nice chap call me back and talk to me for around 15 minutes. Was very impressed. They are a professional group of guys if he os anything to go by. His name was Sting I think, nice South African. Recommend anyone that wants 5 minutes of their time to ask questions does the same.
Market cap $ 16.82 billion...........DYOR
Market Summary > Quest Diagnostics Inc
NYSE: DGX
126.05 USD +0.20 (0.16%)
23 Mar, 10:40 GMT-4 · Disclaimer
now Quest Diagnostics, the
largest clinical laboratory in the world.............
Page 17.............
Dr. Barnhill has been a founder, Chairman and CEO of both private and public companies. He was most
recently founder, Chairman and CEO of a U.S. publicly traded international biotech company, which he took
from inception to profitability. In addition, he was founder, Chairman and CEO of BCL Laboratories, LLC with
operations in south-eastern U.S. which was acquired by Corning–MetPath, now Quest Diagnostics, the
largest clinical laboratory in the world. Dr. Barnhill served as a Medical Director for Quest Diagnostics for
approximately 5 years after the acquisition. Dr. Barnhill was also founder, Chairman and CEO of National
Medical Specialty Labs, which was acquired by Horus Therapeutics Inc., a New York based pharmaceutical
company. Dr. Barnhill served as President of Horus Therapeutics for several years after the acquisition. Dr.
Barnhill is a pioneer in artificial intelligence machine learning (pattern recognition algorithms) and an inventor
on more than 40 patents including neural networks and support vector machines (“SVM”) including the
Hallmark SVM-RFE technique now cited by more than 10,000 publications. His patents were part of the
intellectual property portfolio that won 1st place out of 1600 publicly traded companies and was awarded the